149 related articles for article (PubMed ID: 11738485)
41. Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization.
Hong Y; Zhao Y; Yang L; Gao M; Li L; Man S; Wang Z; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
Eur J Med Chem; 2019 Sep; 178():287-296. PubMed ID: 31195170
[TBL] [Abstract][Full Text] [Related]
42. 1,3,4-oxadiazole derivatives as potential biological agents.
Sun J; Makawana JA; Zhu HL
Mini Rev Med Chem; 2013 Oct; 13(12):1725-43. PubMed ID: 23815585
[TBL] [Abstract][Full Text] [Related]
43. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Khalil NA; Kamal AM; Emam SH
Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC
Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles.
Nieddu V; Pinna G; Marchesi I; Sanna L; Asproni B; Pinna GA; Bagella L; Murineddu G
J Med Chem; 2016 Dec; 59(23):10451-10469. PubMed ID: 27801583
[TBL] [Abstract][Full Text] [Related]
46. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.
Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML
Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
49. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
51. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
52. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
[TBL] [Abstract][Full Text] [Related]
55. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins: Part II. Structure-activity relationship studies.
Cerecetto H; González M; Lavaggi ML; Aravena MA; Rigol C; Olea-Azar C; Azqueta A; de Cerain AL; Monge A; Bruno AM
Med Chem; 2006 Sep; 2(5):511-21. PubMed ID: 17017991
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides.
Abu-Zaied MA; El-Telbani EM; Elgemeie GH; Nawwar GA
Eur J Med Chem; 2011 Jan; 46(1):229-35. PubMed ID: 21115211
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
60. Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives.
De Souza AO; Pedrosa MT; Alderete JB; Cruz AF; Prado MA; Alves RB; Silva CL
Pharmazie; 2005 May; 60(5):396-7. PubMed ID: 15918593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]